{"id":742757,"date":"2023-03-27T08:08:29","date_gmt":"2023-03-27T12:08:29","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\/"},"modified":"2023-03-27T08:08:29","modified_gmt":"2023-03-27T12:08:29","slug":"centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\/","title":{"rendered":"Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BOSTON and LONDON, March  27, 2023  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=K4hjEPLsaHIP0E4nxwhEz39fmodhy75PrzLc9jMp3w1qd2u0pIFVGak9kLOl2AI9gGBPt9WymLbMHlo1Pan4xpw_VXVDSJwoTbiX1pRh058=\" rel=\"nofollow noopener\" target=\"_blank\">Centessa Pharmaceuticals plc<\/a> (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced that members of its management team will participate in the following investor conferences:<\/p>\n<p>\n        <strong>Event:<\/strong>\u00a0Guggenheim Genomic Medicines and Rare Disease Days<br \/><strong>Date:<\/strong> Monday, April 3, 2023<br \/><strong>Location:<\/strong> New York, NY<br \/><strong>Fireside Chat:<\/strong> 9:35 AM ET<\/p>\n<p>\n        <strong>Event:<\/strong> Jefferies &amp; Venrock Boston Biotech Summit<br \/><strong>Date:<\/strong> Wednesday, April 12, 2023<\/p>\n<p>Where applicable, the presentation slides and\/or a link to the live webcast of the event, as well as an archived recording, will be available under the \u201cEvents and Publications\u201d tab on the investor relations section of the Centessa Pharmaceuticals website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LIe7wEtySoAqARLUtWeBrduX9x5pIfpPRFuVqucQtS3eAYtgYHmRs3lYOPN283hFZOPp3In_O34bkQJdUE08LsZGC3ABZzsbPIiPOb8IsQupvaXZobYtRnhKC5VwUZRbb3Xy-DOs8_3MZDvDGaU2gNtWTcpPapSBmdaZrEfKddk=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/investors.centessa.com\/events-presentations<\/a>.<\/p>\n<p>\n        <br \/>\n        <strong>About Centessa Pharmaceutical<\/strong>s<br \/>Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients. Our programs span discovery-stage to late-stage development and cover a range of high-value indications. We operate with the conviction that each one of our programs has the potential to change the current treatment paradigm and establish a new standard of care. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=z8E9g-BDpolGdFkf1O5tgNGyaUEzX3iQY1KwTK71MkGsASXtPYkK2DmscI5gVlp8jQgPNZ2_T4VTLPc4eW07CzF3dfjVEGN1ydrZ-wzw878=\" rel=\"nofollow noopener\" target=\"_blank\">http:\/\/www.centessa.com\/<\/a>, which does not form part of this release.<\/p>\n<p>Contact:<br \/>Kristen K. Sheppard, Esq.<br \/>SVP of Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UfGQz0ybkUvkiqoHG6rmWJb-VwrYpi2-N1e8Qjdw_AXlrigxkG2pE5IGPgKNpVOUSRRoGHLjg6pe30nX7XN_ygH9qex8A6lF07A_RJ3BViU=\" rel=\"nofollow noopener\" target=\"_blank\"><u>investors@centessa.com<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NDY2NCM1NDc2NTk0IzIyMDk0Njc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MThmMzc0YzctMDkyNi00MGZjLTk4OTUtNDIyZGNiNjEzZThjLTEyMjEwMjA=\/tiny\/Centessa-Pharmaceuticals-plc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON and LONDON, March 27, 2023 (GLOBE NEWSWIRE) &#8212; Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced that members of its management team will participate in the following investor conferences: Event:\u00a0Guggenheim Genomic Medicines and Rare Disease DaysDate: Monday, April 3, 2023Location: New York, NYFireside Chat: 9:35 AM ET Event: Jefferies &amp; Venrock Boston Biotech SummitDate: Wednesday, April 12, 2023 Where applicable, the presentation slides and\/or a link to the live webcast of the event, as well as an archived recording, will be available under the \u201cEvents and Publications\u201d tab on the investor relations section of the Centessa Pharmaceuticals website at https:\/\/investors.centessa.com\/events-presentations. About Centessa PharmaceuticalsCentessa Pharmaceuticals &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-742757","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON and LONDON, March 27, 2023 (GLOBE NEWSWIRE) &#8212; Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced that members of its management team will participate in the following investor conferences: Event:\u00a0Guggenheim Genomic Medicines and Rare Disease DaysDate: Monday, April 3, 2023Location: New York, NYFireside Chat: 9:35 AM ET Event: Jefferies &amp; Venrock Boston Biotech SummitDate: Wednesday, April 12, 2023 Where applicable, the presentation slides and\/or a link to the live webcast of the event, as well as an archived recording, will be available under the \u201cEvents and Publications\u201d tab on the investor relations section of the Centessa Pharmaceuticals website at https:\/\/investors.centessa.com\/events-presentations. About Centessa PharmaceuticalsCentessa Pharmaceuticals &hellip; Continue reading &quot;Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-27T12:08:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NDY2NCM1NDc2NTk0IzIyMDk0Njc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2023-03-27T12:08:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\\\/\"},\"wordCount\":218,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NDY2NCM1NDc2NTk0IzIyMDk0Njc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\\\/\",\"name\":\"Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NDY2NCM1NDc2NTk0IzIyMDk0Njc=\",\"datePublished\":\"2023-03-27T12:08:29+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NDY2NCM1NDc2NTk0IzIyMDk0Njc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NDY2NCM1NDc2NTk0IzIyMDk0Njc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\/","og_locale":"en_US","og_type":"article","og_title":"Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"BOSTON and LONDON, March 27, 2023 (GLOBE NEWSWIRE) &#8212; Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced that members of its management team will participate in the following investor conferences: Event:\u00a0Guggenheim Genomic Medicines and Rare Disease DaysDate: Monday, April 3, 2023Location: New York, NYFireside Chat: 9:35 AM ET Event: Jefferies &amp; Venrock Boston Biotech SummitDate: Wednesday, April 12, 2023 Where applicable, the presentation slides and\/or a link to the live webcast of the event, as well as an archived recording, will be available under the \u201cEvents and Publications\u201d tab on the investor relations section of the Centessa Pharmaceuticals website at https:\/\/investors.centessa.com\/events-presentations. About Centessa PharmaceuticalsCentessa Pharmaceuticals &hellip; Continue reading \"Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\/","og_site_name":"Market Newsdesk","article_published_time":"2023-03-27T12:08:29+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NDY2NCM1NDc2NTk0IzIyMDk0Njc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences","datePublished":"2023-03-27T12:08:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\/"},"wordCount":218,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NDY2NCM1NDc2NTk0IzIyMDk0Njc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\/","name":"Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NDY2NCM1NDc2NTk0IzIyMDk0Njc=","datePublished":"2023-03-27T12:08:29+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NDY2NCM1NDc2NTk0IzIyMDk0Njc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NDY2NCM1NDc2NTk0IzIyMDk0Njc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centessa-pharmaceuticals-to-participate-in-upcoming-investor-conferences-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/742757","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=742757"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/742757\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=742757"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=742757"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=742757"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}